Skip to content

In the BioHarmony Drug Report Database

Carboplatin

Paraplatin (carboplatin) is a small molecule pharmaceutical. Carboplatin was first approved as Paraplatin on 1989-03-03. It is used to treat bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, and esophageal neoplasms amongst others in the USA.
Trade Name Paraplatin
Common Name Carboplatin
Indication bone marrow diseases, breast neoplasms, central nervous system neoplasms, endometrial neoplasms, esophageal neoplasms, germ cell and embryonal neoplasms, lung neoplasms, osteosarcoma, ovarian neoplasms, urinary bladder neoplasms
Drug Class Antineoplastics (platinum derivatives)
Carboplatin
Get full access now